Selected Scientific Publications

  1. Miele E et al. Characterization of medulloblastoma in Fanconi Anemia : a novel mutation in BRCA2 gene and SHH molecular subgroup. Biomark Res. 6: 3-13, 2015
  1. Kumar V et al. Notch and NF-kB signaling pathways regulate miR-223/FBXW7 axis in T-cell acute lymphoblastic leukemia. Leukemia 28 (12): 2324-2335, 2014
  1. Palermo R et al. Acetylation controls Notch3 stability and fuction in T-cell leukemia. Oncogene 31(33): 3807-3817, 2012
  1. Napolitano M et al. Protective effect of pioglitazone, a PPARgligand, in a 3-nitropropionic acid model of Huntington’s disease.  Brain Research Bulletin 85: 231-237, 2011
  1. Barbarulo A et al. Notch3 and Canonical NF-{kappa}B Signaling Pathways Cooperatively Regulate Foxp3 Transcription. J Immunol. Jun 1 186 (11): 6199-6206, 2011                  
  1. Napolitano M et al. NF-kB/NOS cross-talk induced by mitochondrial complex II inhibition: implications for Huntington's disease. Neurosci Lett. 434(3): 241-6, 2008.      
  1. Talora C, et al. Notch signaling and diseases: An evolutionary journey from a simple beginning to complex outcomes. Biochim Biophys Acta 1782(9): 489-97, 2008.                                                
  2. Vacca A et al. Notch3 and pre-TCR interaction unveils distinct NF-kappaB pathways in T-cell development and leukemia. EMBO J. 25(5): 1000-8, 2006.    
  1. Talora C et al. Cross talk among Notch3, pre-TCR, and Tal1 in T-cell development and leukemogenesis. Blood. 107(8): 3313-20, 2006.                                                    
  2. Felli MP et al. PKC theta mediates pre-TCR signaling and contributes to Notch3-induced T-cell leukemia. Oncogene. 24(6): 992-1000, 2005.  
  1. Pizza G et al. Allogeneic gene-modified tumour cells in metastatic kidney cancer. Report II. Folia Biol (Praha). 50(6): 175-83, 2004.                                                       
  1. Pizza G et al. Allogeneic gene-modified tumour cells in metastatic kidney cancer. Preliminary report. Folia Biol (Praha) 49(4): 147-59, 2003.          
  1. Maroder M et al. The thymus at the crossroad of neuroimmune interactions. Ann N Y Acad Sci. 917: 741-747, 2000. Review                                             
  1. Napolitano M et al. Expression and relationship between endothelin-1 messenger ribonucleic acid (mRNA) and inducible/endothelial nitric oxide synthase mRNA isoforms from normal and preeclamptic placentas. J Clin Endocrinol Metab. 85(6): 2318-23, 2000.  
  1. Bellavia D et al. Constitutive activation of NF-kappaB and T-cell leukemia/lymphoma in Notch3 transgenic mice. EMBO J. 19: 3337-3348, 2000.                                                                 
  2. Farina AR et al. Transcriptional up-regulation of matrix metalloproteinase-9 expression during spontaneous epithelial to neuroblast phenotype conversion by SK-N-SH neuroblastoma cells, involved in enhanced invasivity, depends upon GT-box and nuclear factor kappaB elements. Cell Growth Differ. 10: 353-67, 1999.                                                                                  
  3. Giannini G et al. HMGI(Y) and HMGI-C genes are expressed in neuroblastoma cell lines and tumors and affect retinoic acid responsiveness Cancer Res. 59(10): 2484-2492, 1999
  1. Felli MP et al. Expression pattern of notch1, 2 and 3 and Jagged1 and 2 in lymphoid and stromal thymus components: distinct ligand-receptor interactions in intrathymic T cell development. Int Immunol. 11(7): 1017-25, 1999                                                                                                    
  2. Napolitano M et al. Modulation of gene expression following long-term synaptic depression in the striatum. Brain Res Mol Brain Res. 8: 89-96, 1999.                                                                       
  3. Vacca A et al. Thrombospondin-1 is a mediator of neurotypic differentiation induced by EGF in thymic epitelian cell.  Experimental Cell Research 248: 79-86, 1999.                                                  
  1. Napolitano M et al. Modulation of cytokine gene expression by thymic lympho-stromal cell to cell interaction: effect of retinoic acid.  Thymus 24: 247-258, 1997
  1. Maroder M et al.  Expression of trkB neurotrophin receptor during T cell development: role of Brain Derived Neurotrophic Factor in immature thymocite survival. Journal of Immunology 157: 2864-2872, 1996   
  1. Maroder M et al.  Human Immunodeficiency Virus Type 1 Tat protein modulates fibronectin expression in thymic epithelial cells and impairs in vitro thimocyte development. Cellular Immunology 168: 49-58, 1996
  1. Petrangeli E et al. Gene methylation of oestrogen and epidermal growth factor receptors in neoplastic and perineoplastic breast tissues. Br J Cancer. 72(4) :973-5, 1995
  1. Ravenna L et al. Androgenic and antiandrogenic control on epidermal growth factor, epidermal growth factor receptor and androgen receptor expression in human prostate cancer cell line LNCaP. Prostate. 26(6): 290-8, 1995
  1. Vacca A et al. Human immunodeficiency virus type-1 tat enhances interleukin-2 promoter activity through synergism with phorbol ester and calcium-mediated activation of the NF-AT cis-regulatory motif. Biochem Biophys Res Commun. 30;205(1):467-74,1994
  1. de Grazia U et al. Positive and negative regulation of the composite octamer motif of the interleukin 2 enhancer by AP-1, Oct-2, and retinoic acid receptor. J Exp Med. 1;180(4):1485-97,1994
  1. Cavallo F et al. Protective and curative potential of vaccination with interleukin-2-gene-transfected cells from a spontaneous mouse mammary adenocarcinoma. Cancer Res. 1;53(21):5067-70,1993
  1. Cavallo F et al. Role of neutrophils and CD4+ T lymphocytes in the primary and memory response to nonimmunogenic murine mammary adenocarcinoma made immunogenic by IL-2 gene. J Immunol. 1;149(11):3627-35,1992
  1. Vacca A et al. Glucocorticoid receptor-mediated suppression of the interleukin 2 gene expression through impairment of the cooperativity between nuclear factor of activated T cells and AP-1 enhancer elements. J Exp Med. 1;175(3):637-46, 1992
  1. Gulino A et al. Calmodulin antagonism and growth-inhibiting activity of triphenylethylene antiestrogens in MCF-7 human breast cancer cells. Cancer Res. 46(12 Pt 1):6274-8, 1986


PubMed ALL Publications